DE2734270A1 - Substituierte 2,3-alkylen-bis(oxy) benzamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel - Google Patents

Substituierte 2,3-alkylen-bis(oxy) benzamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Info

Publication number
DE2734270A1
DE2734270A1 DE19772734270 DE2734270A DE2734270A1 DE 2734270 A1 DE2734270 A1 DE 2734270A1 DE 19772734270 DE19772734270 DE 19772734270 DE 2734270 A DE2734270 A DE 2734270A DE 2734270 A1 DE2734270 A1 DE 2734270A1
Authority
DE
Germany
Prior art keywords
group
benzodioxane
formula
carboxamide
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19772734270
Other languages
German (de)
English (en)
Other versions
DE2734270C2 (US07345094-20080318-C00003.png
Inventor
Jacques Acher
Gerard Dr Bulteau
Claude Collignon
Michel Thominet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
D'etudes Scientifiques Et Industrielles De L'lle-De-France Sa Ste
Original Assignee
D'etudes Scientifiques Et Industrielles De L'lle-De-France Sa Ste
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR7623835A priority Critical patent/FR2360305A1/fr
Application filed by D'etudes Scientifiques Et Industrielles De L'lle-De-France Sa Ste filed Critical D'etudes Scientifiques Et Industrielles De L'lle-De-France Sa Ste
Priority to DE19772734270 priority patent/DE2734270A1/de
Priority to GB32117/77A priority patent/GB1571447A/en
Priority to JP9405677A priority patent/JPS5318570A/ja
Publication of DE2734270A1 publication Critical patent/DE2734270A1/de
Application granted granted Critical
Publication of DE2734270C2 publication Critical patent/DE2734270C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19772734270 1976-08-04 1977-07-29 Substituierte 2,3-alkylen-bis(oxy) benzamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel Granted DE2734270A1 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR7623835A FR2360305A1 (fr) 1976-08-04 1976-08-04 Nouveaux 2,3-alkylene bis (oxy)benzamides substitues, leurs derives et leurs procedes de preparation
DE19772734270 DE2734270A1 (de) 1976-08-04 1977-07-29 Substituierte 2,3-alkylen-bis(oxy) benzamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
GB32117/77A GB1571447A (en) 1976-08-04 1977-08-01 Substituted 2,3-alkyleneduoxybenzamides
JP9405677A JPS5318570A (en) 1976-08-04 1977-08-04 Novel substituted 2*33alkylenebis*oxy*benzamides* thier preparation and medical agent containing same as active ingredient

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7623835A FR2360305A1 (fr) 1976-08-04 1976-08-04 Nouveaux 2,3-alkylene bis (oxy)benzamides substitues, leurs derives et leurs procedes de preparation
DE19772734270 DE2734270A1 (de) 1976-08-04 1977-07-29 Substituierte 2,3-alkylen-bis(oxy) benzamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
DE2734270A1 true DE2734270A1 (de) 1978-02-16
DE2734270C2 DE2734270C2 (US07345094-20080318-C00003.png) 1990-06-21

Family

ID=52850786

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772734270 Granted DE2734270A1 (de) 1976-08-04 1977-07-29 Substituierte 2,3-alkylen-bis(oxy) benzamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Country Status (4)

Country Link
JP (1) JPS5318570A (US07345094-20080318-C00003.png)
DE (1) DE2734270A1 (US07345094-20080318-C00003.png)
FR (1) FR2360305A1 (US07345094-20080318-C00003.png)
GB (1) GB1571447A (US07345094-20080318-C00003.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576448A (en) * 1989-03-22 1996-11-19 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl) (dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8503055D0 (sv) * 1985-06-19 1985-06-19 Astra Laekemedel Ab Piperonylcarboxamido derivatives
FR2586018B1 (fr) * 1985-08-12 1988-03-25 Ile De France Nouveau benzodioxepanne, son procede de synthese et ses applications en therapeutique
GB9027098D0 (en) * 1990-12-13 1991-02-06 Beecham Group Plc Pharmaceuticals

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1602292A (fr) * 1967-02-21 1970-11-02 Fisons Pest Control Ltd Composition pesticide contenant un benzodioxole
DE1518311C (de) * 1972-12-21 Societe dEtudes Scientifiques et Industrielles de LIIe de France, Paris N (2 Diathylaminoathyl) 2 methoxy 3,4 bzw 4,5 methylendioxybenzamid und deren pharmakologisch nicht giftige Saureadditions salze

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518311C (de) * 1972-12-21 Societe dEtudes Scientifiques et Industrielles de LIIe de France, Paris N (2 Diathylaminoathyl) 2 methoxy 3,4 bzw 4,5 methylendioxybenzamid und deren pharmakologisch nicht giftige Saureadditions salze
FR1602292A (fr) * 1967-02-21 1970-11-02 Fisons Pest Control Ltd Composition pesticide contenant un benzodioxole

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Chem. Abstr. 78 (1973), Ref. 4196 *
Chem. Abstr. 83 (1975), Ref. 206184 *
SU-Zurnal Organiceskoj Chimii 3, 1967, H. 6, S.1121-1126

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576448A (en) * 1989-03-22 1996-11-19 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl) (dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives

Also Published As

Publication number Publication date
GB1571447A (en) 1980-07-16
DE2734270C2 (US07345094-20080318-C00003.png) 1990-06-21
JPS5318570A (en) 1978-02-20
FR2360305B1 (US07345094-20080318-C00003.png) 1980-04-18
FR2360305A1 (fr) 1978-03-03
JPS6117832B2 (US07345094-20080318-C00003.png) 1986-05-09

Similar Documents

Publication Publication Date Title
US4306072A (en) Substituted 2,3-alkylene bis (oxy)-4,5 (or 5,6) azimido benzamides and derivatives thereof
DE60132702T2 (de) Heterozyklische verbindungen als inhibitoren von tyrosin-kinasen
EP0533058A1 (de) Imidazo-annellierte Iso- und Heterocyclen, Antagonisten als Angiotensin II
DD216934A5 (de) Verfahren zur herstellung neuer derivate von xanthinen
DE3342164A1 (de) Antipsychotisch wirkende benzoxazine, verfahren zu deren herstellung sowie pharmazeutische zubereitungen, die diese enthalten
DE3125471C2 (de) Piperazinderivate, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
DE4243287A1 (de) N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
DE2444322A1 (de) Triazolopyridazine und verfahren zu deren herstellung
EP0023707B1 (de) Substituierte Tetraazatricyclen, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel
EP0163260A1 (de) Neue substituierte Pyrrolidinone, Verfahren zu ihrer Herstellung und Arzneimittel
DE2804519C2 (US07345094-20080318-C00003.png)
DE19629378A1 (de) Neue Triazolopurine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DD236928A5 (de) Verfahren zur herstellung neuer 1,2,4-triazolo-carbamate
DE2734270A1 (de) Substituierte 2,3-alkylen-bis(oxy) benzamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
WO1995013279A1 (de) N-substituierte azabicycloalkan-derivate, ihre herstellung und verwendung
DE2707270A1 (de) Pyrazolo-diazepine und verfahren zu ihrer herstellung
DE2150062A1 (de) Imidazo- eckige klammer auf 1,2-a eckige klammer zu -pyrido- eckige klammer auf 4,3-d eckige klammer zu -pyrimidine, deren saeureadditionssalze und verfahren zu deren herstellung
EP0621037A1 (de) Pyrido-pyrimidindione, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DD202563A5 (de) Verfahren zur herstellung von 1,5-diphenylpyrazolin-3-on-verbindungen
US4268512A (en) Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation
DE4019080A1 (de) Neue 3,7-diazabicycolo (3,3,1)nonan-verbindungen enthaltende arzneimittel
EP1250317B1 (de) Bis-basische verbindungen als tryptase-inhibitoren, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
US4323503A (en) Substituted 2,3-alkylene di (oxy) benzamides and derivatives
US3586675A (en) Fused thiazines
DE2220716A1 (de) Neue Amido- und Amino-triazolobenzodiazepine und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 2760414

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 2760414

AH Division in

Ref country code: DE

Ref document number: 2760414

Format of ref document f/p: P

AH Division in

Ref country code: DE

Ref document number: 2760414

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee